<p>Novo Nordisk Copenhagen stock price (NOVOB.DC) closed down 1.81%, at 308.80 DKK, with a cumulative decline of 31.70% this week, marking the company's worst single-week performance since its IPO in Denmark. This week, the company announced the promotion of an internal executive to the new CEO during the earnings report. Subsequently, U.S. President Trump called on numerous pharmaceutical companies to lower drug prices in the U.S. market</p>

<p>Novo Nordisk Copenhagen stock price (NOVOB.DC) closed down 1.81%, at 308.80 Danish Krone, with a cumulative decline of 31.70% this week, marking the company's worst weekly performance since its IPO in Denmark. At the same time, the company announced the promotion of an internal executive to the new CEO during the earnings report. Additionally, U.S. President Trump has called for pharmaceutical companies to lower drug prices in the U.S. market</p>

News